Sandbox g08
NDF-RT
- 14-alpha Demethylase Inhibitors
- 5-alpha Reductase Inhibitors
- 5-Lipoxygenase Inhibitors
- Acetyl Aldehyde Dehydrogenase Inhibitors
- Acetylcholine Release Inhibitors
- Acetylcholine Transporter Interactions
- Acid-Base Activity
- Acidifying Activity
- Adenosine Deaminase Inhibitors
- Adenosine Diphosphate Receptor Inhibitors
- Adenosine Receptor Agonists
- Adenosine Receptor Antagonists
- Adenosine Receptor Interactions
- ADH Receptor Antagonists
- Adrenal Steroid Synthesis Inhibitors
- Adrenergic Agonists
- Adrenergic alpha-Agonists
- Adrenergic alpha-Antagonists
- Adrenergic alpha1-Agonists
- Adrenergic alpha1-Antagonists
- Adrenergic alpha2-Agonists
- Adrenergic alpha2-Antagonists
- Adrenergic Antagonists
- Adrenergic beta-Agonists
- Adrenergic beta-Antagonists
- Adrenergic beta1-Agonists
- Adrenergic beta1-Antagonists
- Adrenergic beta2-Agonists
- Adrenergic beta2-Antagonists
- Adrenergic beta3-Agonists
- Adrenergic Receptor Interactions
- Alcohol Dehydrogenase Inhibitors
- Aldosterone Antagonists
- Alkalinizing Activity
- Alkylating Activity
- alpha Glucosidase Inhibitors
- alpha-Particle Emitting Activity
- Ammonium Ion Binding Activity
- AMPA Receptor Antagonists
- Amylase Inhibitors
- Amylin Agonists
- Androgen Receptor Agonists
- Androgen Receptor Antagonists
- Androgen Synthesis Inhibitors
- Angiotensin 2 Receptor Antagonists
- Angiotensin 2 Type 1 Receptor Antagonists
- Angiotensin-converting Enzyme Inhibitors
- Anion Transporter Interactions
- Antibody Interactions
- Antibody-Antibody Interactions
- Antibody-Receptor Interactions
- Antibody-Soluble Protein Interactions
- Antibody-Surface Protein Interactions
- Antidiuretic Hormone Antagonists
- Antigen Neutralization
- Antiporter Interactions
- Antithrombin 3 Activators
- Antithrombin Activators
- Antithrombins
- Aromatase Inhibitors
- ATP-Binding Cassette (ABC) Transporter Interactions
- B Lymphocyte Stimulator-directed Antibody Interactions
- Bacterial Neurotoxin Neutralization
- Bacterial Toxin Neutralization
- Bcr-Abl Tyrosine Kinase Inhibitors
- beta Lactamase Inhibitors
- beta Tubulin Interactions
- Bile-acid Binding Activity
- Binding Activity
- Biological Macromolecular Activity
- Biological Response Modifiers
- Bone Surface Interactions
- Bradykinin B2 Receptor Antagonists
- Bradykinin Receptor Antagonists
- Bradykinin Receptor Interactions
- BRAF Serine/Threonine Kinase Inhibitors
- Breast Cancer Resistance Protein Inhibitors
- Breast Cancer Resistance Protein Interactions
- Calcineurin Inhibitors
- Calcium Channel Agonists
- Calcium Channel Antagonists
- Calcium Channel Interactions
- Calcium Chelating Activity
- Calcium-Sensing Receptor Interactions
- Cannabinoid Receptor Agonists
- Cannabinoid Receptor Antagonists
- Cannabinoid Receptor Interactions
- Carbamoyl Phosphate Synthetase 1 Activators
- Carbonic Anhydrase Inhibitors
- Catechol O-Methyltransferase Inhibitors
- Catecholamine Synthesis Inhibitors
- Cation Transporter Interactions
- CD11a-directed Antibody Interactions
- CD19-directed Antibody Interactions
- CD2-directed Antibody Interactions
- CD20-directed Antibody Interactions
- CD25-directed Receptor Interactions
- CD3 Receptor Agonists
- CD3 Receptor Antagonists
- CD3 Receptor Interactions
- CD3-directed Antibody Interactions
- CD30-directed Antibody Interactions
- CD33-directed Antibody Interactions
- CD52-directed Antibody Interactions
- CD80-directed Antibody Interactions
- CD86-directed Antibody Interactions
- Cell Membrane Fusion Complex Interactions
- Cellular or Molecular Interactions
- Cellular Structure Molecule Interactions
- Chelating Activity
- Chemokine Co-receptor 5 Antagonists
- Chemokine Co-receptor 5 Interactions
- Chloride Channel Activation Potentiators
- Chloride Channel Activators
- Chloride Channel Agonists
- Chloride Channel Antagonists
- Chloride Channel Interactions
- Cholesterol Synthesis Inhibitors
- Cholinergic Agonists
- Cholinergic Antagonists
- Cholinergic Ganglionic Nicotinic Agonists
- Cholinergic Ganglionic Nicotinic Antagonists
- Cholinergic Interactions
- Cholinergic Muscarinic Agonists
- Cholinergic Muscarinic Antagonists
- Cholinergic Muscarinic Receptor Interactions
- Cholinergic Neuromuscular Nicotinic Agonists
- Cholinergic Neuromuscular Nicotinic Antagonists
- Cholinergic Nicotinic Agonists
- Cholinergic Nicotinic Antagonists
- Cholinergic Nicotinic Receptor Interactions
- Cholinesterase Inhibitors
- Cholinesterase Reactivators
- Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors
- Competitive Cholinergic Nicotinic Antagonists
- Competitive NMDA Receptor Antagonists
- Competitive Opioid Antagonists
- Complement 1 Inactivators
- Complement 5 Inactivators
- Complement Inactivators
- Complement Inhibitors
- Copper Chelating Activity
- Corticosteroid Hormone Receptor Agonists
- CTLA-4-directed Antibody Interactions
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Cysteine Proteinase Inhibitors
- Cystine Disulfide Reduction
- Cytochrome P450 17A1 Inhibitors
- Cytochrome P450 1A2 Inducers
- Cytochrome P450 1A2 Inhibitors
- Cytochrome P450 2B6 Inducers
- Cytochrome P450 2B6 Inhibitors
- Cytochrome P450 2C19 Inducers
- Cytochrome P450 2C19 Inhibitors
- Cytochrome P450 2C8 Inducers
- Cytochrome P450 2C8 Inhibitors
- Cytochrome P450 2C9 Inducers
- Cytochrome P450 2C9 Inhibitors
- Cytochrome P450 2D6 Inducers
- Cytochrome P450 2D6 Inhibitors
- Cytochrome P450 3A Inducers
- Cytochrome P450 3A Inhibitors
- Cytochrome P450 3A4 Inducers
- Cytochrome P450 3A4 Inhibitors
- Cytochrome P450 3A5 Inducers
- Cytochrome P450 3A5 Inhibitors
- Cytochrome P450 Inducers
- Cytochrome P450 Inhibitors
- Cytokine Receptor Superfamily Interactions
- Decarboxylase Inhibitors
- Decreased Calcium-sensing Receptor Sensitivity
- Demulcent Activity
- Dephosphorylation Inhibitors
- Digoxin Binding Activity
- Dihydrofolate Reductase Inhibitors
- Dihydroorotate Dehydrogenase Inhibitors [MoA]
- Dipeptidase Inhibitors
- Dipeptidyl Peptidase 4 Inhibitors
- Disulfide Reduction
- DNA Gyrase Inhibitors
- DNA Methyltransferase Inhibitors
- DNA Polymerase Inhibitors
- DOPA Decarboxylase Inhibitors
- Dopamine Agonists
- Dopamine Antagonists
- Dopamine D2 Antagonists
- Dopamine Receptor Interactions
- Dopamine Transporter Interactions
- Dopamine Uptake Inhibitors
- Dyes
- E3 Ubiquitin Ligase Inhibitors
- Electrolyte Activity
- Endogenous Antigen Neutralization
- Endothelin Receptor Agonists
- Endothelin Receptor Antagonists
- Endothelin Receptor Interactions
- Enkephalinase Inhibitors
- Enzymatic Activity
- Enzyme Activators
- Enzyme Inducers
- Enzyme Inhibitors
- Enzyme Interactions
- Enzyme Reactivators
- Ergosterol Synthesis Inhibitors
- Estradiol Antagonists
- Estrogen Receptor Agonists
- Estrogen Receptor Antagonists
- Estrogen Receptor Modulators
- Estrogen Synthesis Inhibitors
- Factor Xa Inhibitors
- Fatty Acid Synthetase Inhibitors
- Fatty Acid Transporter Interactions
- Folic Acid Metabolism Inhibitors
- Free Radical Scavenging Activity
- Full Cholinergic Nicotinic Agonists
- Full Opioid Agonists
- Fusion Protein Inhibitors
- Fusion Protein Interactions
- G-Protein-linked Receptor Interactions
- GABA A Agonists
- GABA A Antagonists
- GABA A Modulators
- GABA A Receptor Interactions
- GABA B Agonists
- GABA B Antagonists
- GABA B Modulators
- GABA B Receptor Interactions
- gamma-Ray Emitting Activity
- Glucagon Receptor Interactions
- Glucagon-like Peptide-1 (GLP-1) Agonists
- Glucagon-like Peptide-1 (GLP-1) Antagonists
- Glucagon-like Peptide-1 (GLP-1) Receptor Interactions
- Glucagon-like Peptide-2 (GLP-2) Agonists
- Glucagon-like Peptide-2 (GLP-2) Antagonists
- Glucagon-like Peptide-2 (GLP-2) Receptor Interaction
- Glucan Synthase Inhibitors
- Glucocorticoid Receptor Agonists
- Glucocorticoid Receptor Antagonists
- Glucocorticoid Synthesis Inhibitors
- Glucosyl Transferase Inhibitors
- Glucosylceramide Synthase Inhibitors
- Glycine Agonists
- Glycine Antagonists
- Glycine Receptor Interactions
- Gonadotropin Releasing Hormone Receptor Agonists
- Gonadotropin Releasing Hormone Receptor Antagonists
- Growth Hormone Receptor Agonists
- Growth Hormone Receptor Antagonists
- GTP Phosphohydrolase Activators
- Guanylate Cyclase Activators
- Guanylate Cyclase Stimulators
- HCV NS3/4A Protease Inhibitors
- Heparin Binding Activity
- HER Receptor Family Antagonists
- HER Receptor Family Interactions
- HER1 Antagonists
- HER2/Neu/cerbB2 Antagonists
- HER3 Antagonists
- Histamine Agonists
- Histamine H1 Receptor Antagonists
- Histamine H2 Receptor Antagonists
- Histamine H3 Receptor Antagonists
- Histamine Receptor Antagonists
- Histamine Receptor Interactions
- Histone Deacetylase Inhibitors
- HIV Fusion Protein Inhibitors
- HIV Integrase Inhibitors
- HIV Protease Inhibitors
- Hormone Receptor Agonists
- Hormone Receptor Antagonists
- Hormone Receptor Interactions
- Hormone Receptor Modulators
- Hydroxylase Activators
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxyphenylpyruvate Dioxygenase Inhibitors
- Hypothalamic Hormone Receptor Agonists
- Hypothalamic Hormone Receptor Antagonists
- Hypothalmic Hormone Interactions
- IgE-directed Antibody Interactions
- IGF Type 1 Receptor Interactions
- Imaging Contrast Activity
- Immunologic Adjuvants
- Immunologic and Biological Factor Interactions
- Immunologic Factor Interactions
- Increased Calcium-sensing Receptor Sensitivity
- Insulin Receptor Agonists
- Insulin Receptor Antagonists
- Insulin Receptor Interactions
- Integrase Inhibitors
- Integrin Receptor Antagonists
- Integrin Receptor Interactions
- Interferon Inducers
- Interleukin 1 Receptor Agonists
- Interleukin 1 Receptor Antagonists
- Interleukin 1 Receptor Interactions
- Interleukin 2 Receptor Agonists
- Interleukin 2 Receptor Antagonists
- Interleukin 2 Receptor Interactions
- Interleukin 2 Receptor-directed Antibody Interactions
- Interleukin 6 Receptor Agonists
- Interleukin 6 Receptor Antagonists
- Interleukin 6 Receptor Interactions
- Interleukin-6 Antagonists
- Interleukin-6-directed Antibody Interactions
- Iodide Peroxidase Inhibitors
- Ion Channel Interactions
- Ion Exchange Activity
- Ion Transporter Interactions
- Ionophoric Activity
- Ionotropic Glutamate Receptor Antagonists
- Ionotropic Glutamate Receptor Interactions
- Iron Chelating Activity
- Irrigation
- Janus Kinase Inhibitors
- Kainate Receptor Antagonists
- Kallikrein Inhibitors
- Keratinocyte Growth Factor Receptor Agonists
- Keratinocyte Growth Factor Receptor Antagonists
- Keratinocyte Growth Factor Receptor Interactions
- Kinase Inhibitors
- L-Calcium Channel Receptor Antagonists
- Lead Chelating Activity
- Leukotriene Receptor Antagonists
- Leukotriene Receptor Interactions
- Ligand-Gated Ion Channel Interactions
- Ligase Activators
- Lipase Inhibitors
- Lipoxygenase Inhibitors
- Lyase Activators
- Lysophospholipid Receptor Interactions
- Lysosphingolipid Receptor Interactions
- M2 Protein Inhibitors
- Macrophage Colony Stimulating Factor Receptor Interactions
- Magnesium Ion Exchange Activity
- Magnetic Resonance Contrast Activity
- Melanin Synthesis Inhibitors
- Melatonin Receptor Agonists
- Melatonin Receptor Interactions
- Membrane Transporter Interactions
- Metal Chelating Activity
- Methylating Activity
- Microsomal Triglyceride Transfer Protein Inhibitors
- Microsomal Triglyceride Transfer Protein Interactions
- Mineralocorticoid Receptor Agonists
- Mineralocorticoid Receptor Antagonists
- Mineralocorticoid Synthesis Inhibitors
- Monoamine Oxidase Inhibitors
- Monoamine Oxidase-A Inhibitors
- Monoamine Oxidase-B Inhibitors
- Monosaccharide Transporter Interactions
- mTOR Inhibitors
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors
- N-Calcium Channel Receptor Antagonists
- Neuraminidase Inhibitors
- Neurokinin 1 Antagonists
- Neurokinin 1 Receptor Interactions
- Neurotransmitter Transporter Interactions
- Neurotrophic Factor Receptor (RET) Inhibitors
- Nitric Oxide Donors
- Nitric Oxide Synthase Inhibitors
- NMDA Receptor Antagonists
- NMDA Receptor Glycine Antagonists
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Noncompetitive Cholinergic Nicotinic Antagonists
- Noncompetitive NMDA Receptor Antagonists
- Noncompetitive Opioid Antagonists
- Norepinephrine Transporter Interactions
- Norepinephrine Uptake Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Nucleoside Reverse Transcriptase Inhibitors
- Nucleoside Synthesis Inhibitors
- Opioid Agonists
- Opioid Antagonists
- Opioid Receptor Interactions
- Orexin Receptor Agonists
- Orexin Receptor Antagonists
- Orexin Receptor Interactions
- Organic Anion Transporter 1 Inhibitors
- Organic Anion Transporter 3 Inhibitors
- Organic Anion Transporter Interactions
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 1B3 Inhibitors
- Organic Anion Transporting Polypeptide 2B1 Inhibitors
- Organic Cation Transporter 1 Inhibitors
- Organic Cation Transporter 2 Inhibitors
- Organic Cation Transporter Interactions
- Osmotic Activity
- Oxidation Activity
- Oxidation-Reduction Activity
- P-Glycoprotein Inducers
- P-Glycoprotein Inhibitors
- P-Glycoprotein Interactions
- P2Y12 Receptor Antagonists
- Para-Aminobenzoic Acid Inhibitors
- Parathormone Receptor Agonists
- Parathormone Receptor Antagonists
- Parathormone Receptor Interactions
- Partial Cholinergic Nicotinic Agonists
- Partial Opioid Agonists
- Peroxisome Proliferator-activated Receptor Activity
- Peroxisome Proliferator-activated Receptor alpha Agonists
- Peroxisome Proliferator-activated Receptor beta Agonists
- Peroxisome Proliferator-activated Receptor delta Agonists
- Peroxisome Proliferator-activated Receptor gamma Agonists
- Phenylalanine Hydroxylase Activators
- Phosphate Chelating Activity
- Phosphodiesterase 3 Inhibitors
- Phosphodiesterase 4 Inhibitors
- Phosphodiesterase 5 Inhibitors
- Phosphodiesterase Inhibitors
- Photoabsorption
- Physiochemical Activity
- Pituitary Hormone Receptor Agonists
- Pituitary Hormone Receptor Antagonists
- Pituitary Hormones Receptor Interactions
- Plasmin Inhibitors
- Plasminogen Activators
- Platelet Activating Factor Inhibitors
- Platelet Glycoprotein IIb/IIIA Inhibitors
- Platelet-derived Growth Factor alpha Receptor Inhibitors
- Platelet-derived Growth Factor alpha Receptor Interactions
- Platelet-derived Growth Factor beta Receptor Inhibitors
- Platelet-derived Growth Factor beta Receptor Interactions
- Platelet-derived Growth Factor Receptor Inhibitors
- Plutonium Chelating Activity
- Polyvalent Cation Chelating Activity
- Positron Emitting Activity
- Potassium Channel Agonists
- Potassium Channel Antagonists
- Potassium Channel Interactions
- Potassium Channel Openers
- Potassium Ion Binding Activity
- Potassium Ion Exchange Activity
- Progestational Hormone Receptor Agonists
- Progestational Hormone Receptor Antagonists
- Progestin Synthesis Inhibitors
- Programmed Death Receptor-1-directed Antibody Interactions
- Prostacyclin Receptor Agonists
- Prostaglandin Receptor Agonists
- Prostaglandin Receptor Antagonists
- Prostaglandin Receptor Interactions
- Protease Inhibitors
- Protease-activated Receptor Interactions
- Protease-activated Receptor-1 Antagonists
- Protease-activated Receptor-1 Interactions
- Proteasome Inhibitors
- Protein Kinase Inhibitors
- Protein Synthesis Inhibitors
- Proton Pump Inhibitors
- Proton Pump Interactions
- Radiopharmaceutical Activity
- RANK Ligand Blocking Activity
- Receptor Activity Modifying Protein Agonists
- Receptor Activity Modifying Protein Antagonists
- Receptor Activity Modifying Proteins
- Receptor Interactions
- Receptor Protein Kinase Interactions
- Receptor Tyrosine Kinase Inhibitors
- Reduction Activity
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- Ribonucleotide Reductase Inhibitors
- RNA Replicase Inhibitors
- RNA Synthetase Inhibitors
- Sclerosing Activity
- Secretin Receptor Agonists
- Secretin Receptor Antagonists
- Secretin Receptor Interactions
- Selective Estrogen Receptor Modulators
- Selective Progesterone Receptor Modulators
- Serine Proteinase Inhibitors
- Serotonin 1b Receptor Agonists
- Serotonin 1d Receptor Agonists
- Serotonin 2c Receptor Agonists
- Serotonin 3 Receptor Antagonists
- Serotonin 4 Receptor Antagonists
- Serotonin 5HT-3 Agonists
- Serotonin 5HT-3 Antagonists
- Serotonin 5HT-3 Receptor Interactions
- Serotonin Agonists
- Serotonin Antagonists
- Serotonin Receptor Interactions
- Serotonin Transporter Interactions
- Serotonin Uptake Inhibitors
- Sex Hormone Receptor Agonists
- Sex Hormone Receptor Antagonists
- Sex Hormone Synthesis Inhibitors
- Siderophore Iron Chelating Activity
- Sigma Receptor Interactions
- Sigma-1 Receptor Agonists
- Sigma-1 Receptor Antagonists
- Sigma-1 Receptor Interactions
- Smoothened Receptor Antagonists
- Smoothened Receptor Interactions
- Sodium Channel Agonists
- Sodium Channel Antagonists
- Sodium Channel Interactions
- Sodium Chloride Symporter Inhibitors
- Sodium Chloride Symporter Interactions
- Sodium Potassium Chloride Symporter Inhibitors
- Sodium Potassium Chloride Symporter Interactions
- Sodium-Glucose Transporter 1 Inhibitors
- Sodium-Glucose Transporter 2 Inhibitors
- Sodium-Glucose Transporter Inhibitors
- Sodium-Glucose Transporter Interactions
- Sodium-Potassium Exchanging ATPase Interactions
- Somatostatin Receptor Agonists
- Somatostatin Receptor Interactions
- Somatotropin Receptor Agonists
- Somatotropin Receptor Interactions
- Sphingosine 1-Phosphate Receptor Interactions
- Sphingosine 1-Phosphate Receptor Modulators
- Squalene Monooxygenase Inhibitors
- Stem Cell Factor (KIT) Receptor Inhibitors
- Steroid Hormone Receptor Agonists
- Steroid Receptor Antagonists
- Steroid Receptor Modulators
- Steroid Synthesis Inhibitors
- Sterol Synthesis Inhibitors
- Stool Bulking Activity
- Structural Macromolecules
- Sulfate Donors
- Surfactant Activity
- Symporter Interactions
- Synaptic Fusion Complex Interactions
- T-Calcium Channel Receptor Antagonists
- Thrombin Inhibitors
- Thrombopoietin Receptor Agonists
- Thrombopoietin Receptor Interactions
- Thymidylate Synthetase Inhibitors
- Thyroid Hormone Receptor Agonists
- Thyroid Hormone Receptor Antagonists
- Thyroid Hormone Synthesis Inhibitors
- Tissue Plasminogen Activator Inhibitors
- Tissue Plasminogen Activators
- Topoisomerase 1 Inhibitors
- Topoisomerase 2 Inhibitors
- Topoisomerase 4 Inhibitors
- Topoisomerase Inhibitors
- Transcription Factor Activity
- Transpeptidase Inhibitors
- Trypsin Inhibitors
- Tubulin Interactions
- Tumor Necrosis Factor alpha Receptor Blocking Activity
- Tumor Necrosis Factor beta Receptor Blocking Activity
- Tumor Necrosis Factor Receptor Blocking Activity
- Tumor Necrosis Factor Receptor Interactions
- Tyrosine Kinase Inhibitors
- Ubiquitin Ligase Inhibitors
- UDP Glucuronosyltransferases Inducers
- UDP Glucuronosyltransferases Inhibitors
- UGT1A Inhibitors
- UGT1A1 Inhibitors
- UGT1A3 Inhibitors
- UGT1A4 Inhibitors
- UGT1A6 Inhibitors
- UGT1A9 Inhibitors
- UGT2B Inhibitors
- UGT2B15 Inhibitors
- UGT2B7 Inhibitors
- Ultrasound Contrast Activity
- Ultraviolet A Radiation Absorption
- Ultraviolet B Radiation Absorption
- Uncompetitive NMDA Receptor Antagonists
- Uncouplers
- Unknown Cellular or Molecular Interaction
- Urease Inhibitors
- Vascular Endothelial Growth Factor Receptor 2-directed Antibody Interactions
- Vascular Endothelial Growth Factor Receptor Inhibitors
- Vascular Endothelial Growth Factor-directed Antibody Interactions
- VEGFR1 Inhibitors
- VEGFR2 Inhibitors
- VEGFR3 Inhibitors
- Venom Neutralization
- Vesicular Monoamine Transporter 2 Inhibitors
- Vesicular Monoamine Transporter Antagonists
- Vesicular Monoamine Transporter Interactions
- Viral Envelope Interactions
- Virus Neutralization
- Vitamin K Epoxide Reductase Inhibitors
- Vitamin K Inhibitors
- Voltage-gated Calcium Channel Receptor Antagonists
- X-Ray Contrast Activity
- Xanthine Oxidase Inhibitors